Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 44 (ZNF44) is a member of the zinc finger protein family, characterized by the C2H2-type zinc finger DNA-binding motif. As a transcription factor, it binds to specific DNA sequences and regulates gene expression, primarily functioning as a transcriptional regulator for RNA polymerase II-dependent genes. Zinc finger proteins, including ZNF44, are highly versatile and can bind DNA, RNA, and proteins, participating in vital cellular processes such as cell differentiation, apoptosis, metabolism, stemness maintenance, and immune response. Zinc finger proteins overall are extensively studied in relation to cancer progression and potential clinical utility as therapeutic and diagnostic targets, although no direct drugs or clinical biomarkers are established for ZNF44. None specifically reported for ZNF44 as of current data. No drugs are cited to interact directly with ZNF44, though targeting zinc finger proteins as a class is possible. There are no validated biomarkers for ZNF44 patient selection or efficacy monitoring specifically; zinc finger proteins are emerging as prognostic markers in several cancers (e.g., hepatocellular carcinoma, but ZNF44 not listed as major marker). ZNF44’s aliases refer to different database entries, historical names, and alternative splice variants often used in the genomics and proteomics literature. The full spectrum of biological and clinical roles for ZNF44 may yet be underexplored, but the protein typifies zinc finger proteins' function in transcriptional regulation and gene expression control.
Not applicable—no known drugs directly target ZNF44, but the general mechanism would be inhibition or modulation of transcription factor activity via DNA binding site blocking, degradation, or interfering protein-protein interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 44 (ZNF44).